pyrazines has been researched along with Cytomegalovirus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blancho, G; Branchereau, J; Breimer, ME; Charreau, B; Châtelais, M; Cowan, PJ; Cozzi, E; Crossan, C; d'Apice, AJ; Daha, MR; Dilek, N; Diswall, M; Duchi, R; Galli, C; Hervouet, J; Klar, N; Lagutina, I; Lazzari, G; Le Bas-Bernardet, S; Minault, D; Nottle, MB; Perota, A; Poirier, N; Renaudin, K; Robson, SC; Sachs, DH; Salvaris, EJ; Scobie, L; Simioni, P; Soulillou, JP; Takeuchi, Y; Tillou, X; Vanhove, B; Yamada, K | 1 |
| Blanco, B; Caballero-Velázquez, T; Inogés, S; Pérez-Simón, JA; Sánchez-Abarca, LI; Santamaría, C | 1 |
| Goulston, C; Hanson, KE; Kim, JH; Lampas, M; Sanders, S; Tricot, G; Zangari, M | 1 |
| Galimberti, S; Orciuolo, E; Petrini, M | 1 |
| Drach, JC; Liu, W; Townsend, LB; Walker, JA; Wise, DS | 1 |
| Aubertin, AM; Benhaddou, R; Davis, J; Demonte, M; Granet, R; Krausz, P | 1 |
6 other study(ies) available for pyrazines and Cytomegalovirus
| Article | Year |
|---|---|
Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons.
Topics: Animals; Animals, Genetically Modified; Autoimmune Diseases; Boronic Acids; Bortezomib; Complement C1 Inhibitor Protein; Cytomegalovirus; Galactosyltransferases; Gene Knockout Techniques; Graft Survival; Heterografts; Immunity, Innate; Immunosuppressive Agents; Kidney; Kidney Transplantation; Models, Animal; Papio anubis; Plasma Exchange; Pyrazines; Sus scrofa; Virus Replication | 2015 |
Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cytomegalovirus; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; In Vitro Techniques; Interferon-gamma; Lymphocyte Activation; Lymphocyte Depletion; Proteasome Inhibitors; Pyrazines; T-Lymphocytes; Transplantation, Homologous | 2011 |
Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.
Topics: Aged; Antiviral Agents; Boronic Acids; Bortezomib; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Pyrazines; Retrospective Studies; Risk Factors; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Viral Load; Viremia; Virus Activation | 2012 |
Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitro.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cytomegalovirus; Dose-Response Relationship, Drug; Enterotoxins; Humans; In Vitro Techniques; Pyrazines; T-Lymphocytes | 2007 |
Synthesis and antiviral evaluation of certain novel pyrazinoic acid C-nucleosides.
Topics: Antiviral Agents; Cell Division; Cell Survival; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Herpesvirus 1, Human; Humans; KB Cells; Microbial Sensitivity Tests; Pyrazines; Ribose; Skin; Viral Plaque Assay | 1998 |
Synthesis and antiviral evaluation of pyrazinones substituted with acyclic chains.
Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Drug Design; Enterovirus B, Human; Herpesvirus 1, Human; Humans; Microbial Sensitivity Tests; Models, Chemical; Pyrazines; Vaccinia virus | 1998 |